Health Canada added that it is currently reviewing eight other submissions for generic semaglutide by different companies and expects to make additional regulatory decisions in the coming weeks and months. The regulator said its review ensures that differences between the generic products and the reference biologic do not affect the safety, efficacy, or quality of the drug. It added that the availability of generic drugs is expected to have a positive impact in Canada, including potential cost savings for patients and the healthcare system, and that many generic medicines in Canada are 45% to 90% cheaper than their brandname counterparts
Dehydration-related renal impairment is a risk, particularly in patients with pre-existing kidney disease
Overall, about 34% of patients adhering to treatment lost 20% or more of their body weight, versus about 3% of those on placebo, the company said
Here are the exact storage requirements backed by stability data
Supporting overall health Sermorelin also offers broader health benefits, including enhanced sleep quality, increased energy, and improved mood